Teoxane S A Les Charmillesrue De Lyon 105geneva 1203 Pma Numberp170002 Supplement Numbers025 Date Received12 27 2022 Decision Date01 26 2023 Product Code Lmh Advisory Committee General Plastic Surgery Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Teoxane S A Les Charmillesrue De Lyon 105geneva 1203 Pma Numberp170002 Supplement Numbers025 Date Received12 27 2022 Decision Date01 26 2023 Product Code Lmh Advisory Committee General Plastic Surgery Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P170002S025 TEOXANE S.A.les Charmillesrue De Lyon 105geneva 1203 PMA NumberP170002 Supplement NumberS025 Date Received12/27/2022 Decision Date01/26/2023 Product Code LMH  Advisory Committee General & Plastic Surgery Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No	RHA® Redensity™, RHA ®2, RHA ®3, RHA ®4 dermal fillers	2023-01-26